Other Open Access
Meredith Smith; Serena Oliveri; Monica Casiraghi
{ "files": [ { "links": { "self": "https://zenodo.org/api/files/e357741a-5fdb-4cf7-abb3-faf32e99d7c3/Treating%20non-small%20cell%20lung%20cancer%20-%20What%20do%20patients%20PREFER.pdf" }, "checksum": "md5:bb05f24ccc53503147f1ee40dc433d3a", "bucket": "e357741a-5fdb-4cf7-abb3-faf32e99d7c3", "key": "Treating non-small cell lung cancer - What do patients PREFER.pdf", "type": "pdf", "size": 795397 } ], "owners": [ 253123 ], "doi": "10.5281/zenodo.6260511", "stats": { "version_unique_downloads": 106.0, "unique_views": 169.0, "views": 185.0, "version_views": 185.0, "unique_downloads": 106.0, "version_unique_views": 169.0, "volume": 95447640.0, "version_downloads": 120.0, "downloads": 120.0, "version_volume": 95447640.0 }, "links": { "doi": "https://doi.org/10.5281/zenodo.6260511", "conceptdoi": "https://doi.org/10.5281/zenodo.6260510", "bucket": "https://zenodo.org/api/files/e357741a-5fdb-4cf7-abb3-faf32e99d7c3", "conceptbadge": "https://zenodo.org/badge/doi/10.5281/zenodo.6260510.svg", "html": "https://zenodo.org/record/6260511", "latest_html": "https://zenodo.org/record/6260511", "badge": "https://zenodo.org/badge/doi/10.5281/zenodo.6260511.svg", "latest": "https://zenodo.org/api/records/6260511" }, "conceptdoi": "10.5281/zenodo.6260510", "created": "2022-02-25T10:08:05.630215+00:00", "updated": "2022-05-30T13:37:26.641257+00:00", "conceptrecid": "6260510", "revision": 3, "id": 6260511, "metadata": { "access_right_category": "success", "doi": "10.5281/zenodo.6260511", "description": "<p>We wanted to learn about lung cancer patients’ preferences for new treaments, and what they considered to be the maximum acceptable risk, and the minimum acceptable benefit of a treatment.</p>", "contributors": [ { "affiliation": "KU Leuven", "type": "Researcher", "name": "Rosanne Janssens" }, { "affiliation": "KU Leuven", "type": "Researcher", "name": "Isabelle Huys" }, { "affiliation": "University Medical Centre Utrecht", "type": "Researcher", "name": "Ian Smith" }, { "affiliation": "European Cancer Patient Coalition", "type": "Researcher", "name": "Charis Girvalaki" }, { "affiliation": "University Medical Centre Utrecht", "type": "Researcher", "name": "Ardine de Wit" }, { "affiliation": "Erasmus University Rotterdam", "type": "Researcher", "name": "Jorien Veldwijk" }, { "affiliation": "European Institute of Oncology", "type": "Researcher", "name": "Lucilla Lanzoni" } ], "title": "Treating non-small cell lung cancer: What do patients PREFER", "license": { "id": "CC-BY-4.0" }, "relations": { "version": [ { "count": 1, "index": 0, "parent": { "pid_type": "recid", "pid_value": "6260510" }, "is_last": true, "last_child": { "pid_type": "recid", "pid_value": "6260511" } } ] }, "communities": [ { "id": "prefer" } ], "grants": [ { "code": "115966", "links": { "self": "https://zenodo.org/api/grants/10.13039/501100000780::115966" }, "title": "Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966", "acronym": "PREFER", "program": "H2020", "funder": { "doi": "10.13039/501100000780", "acronyms": [], "name": "European Commission", "links": { "self": "https://zenodo.org/api/funders/10.13039/501100000780" } } } ], "keywords": [ "Plain language summary", "Case study" ], "publication_date": "2022-02-24", "creators": [ { "affiliation": "Alexion", "name": "Meredith Smith" }, { "affiliation": "European Institute of Oncology", "name": "Serena Oliveri" }, { "affiliation": "European Institute of Oncology", "name": "Monica Casiraghi" } ], "access_right": "open", "resource_type": { "type": "other", "title": "Other" }, "related_identifiers": [ { "scheme": "doi", "identifier": "10.5281/zenodo.6260510", "relation": "isVersionOf" } ] } }
All versions | This version | |
---|---|---|
Views | 185 | 185 |
Downloads | 120 | 120 |
Data volume | 95.4 MB | 95.4 MB |
Unique views | 169 | 169 |
Unique downloads | 106 | 106 |